An in-depth look to NOVONESIS (NOVOZYMES A/S) B operating, investing, and financing activities

NSIS_B free cash flow for H1 24 is 2.93 B DKK. For 2023, NSIS_B free cash flow was 2.29 B DKK and operating cash flow was 4.15 B DKK.